Global Influenza diagnostics Market to reach USD 3.6 billion by 2026

Global Influenza diagnostics Market Size study By Test Type (RIDT, RT-PCR, Cell Culture), By End-use (Hospitals, Laboratories, POCT) and by Regional Forecasts 2019-2026
Product Code:  HALMD_82656715
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Influenza diagnostics Market, by Region, 2017-2026 (USD Billion)
1.2.2.	Influenza diagnostics Market, by Test type, 2017-2026 (USD Billion)
1.2.3.	Influenza diagnostics Market, by End Use, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Influenza diagnostics Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Influenza diagnostics Market Dynamics	
3.1.	Influenza diagnostics Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Influenza diagnostics Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Influenza diagnostics Market, by Test type 
5.1.	Market Snapshot 
5.2.	Global Influenza diagnostics Market by Test type, Performance - Potential Analysis
5.3.	Global Influenza diagnostics Market Estimates & Forecasts by Test type 2016-2026 (USD Billion)
5.4.	Influenza diagnostics Market, Sub Segment Analysis
5.4.1.	RIDT
5.4.2.	 RT-PCR
5.4.3.	 Cell culture
Chapter 6.	Global Influenza diagnostics Market, by End Use          
6.1.	Market Snapshot 
6.2.	Global Influenza diagnostics Market by End Use, Performance - Potential Analysis
6.3.	Global Influenza diagnostics Market Estimates & Forecasts by End Use 2016-2026 (USD Billion)
6.4.	Influenza diagnostics Market, Sub Segment Analysis
6.4.1.	Hospitals
6.4.2.	Laboratories
6.4.3.	POCT
Chapter 7.	Global Influenza diagnostics Market, Regional Analysis
7.1.	Influenza diagnostics Market, Regional Market Snapshot 
7.2.	North America Influenza diagnostics Market 
7.2.1.	U.S. Influenza diagnostics Market
7.2.1.1.	 Test type breakdown estimates & forecasts, 2016-2026 
7.2.1.2.	 End Use breakdown estimates & forecasts, 2016-2026 
7.2.2.	Canada Influenza diagnostics Market
7.3.	Europe Influenza diagnostics Market Snapshot
7.3.1.	U.K. Influenza diagnostics Market 
7.3.2.	Germany Influenza diagnostics Market
7.3.3.	Rest of Europe Influenza diagnostics Market
7.4.	Asia-Pacific Influenza diagnostics Market Snapshot
7.4.1.	China Influenza diagnostics Market 
7.4.2.	India Influenza diagnostics Market 
7.4.3.	Japan Influenza diagnostics Market
7.4.4.	Rest of Asia Pacific Influenza diagnostics Market
7.5.	Latin America Influenza diagnostics Market Snapshot
7.5.1.	Brazil Influenza diagnostics Market
7.5.2.	Mexico Influenza diagnostics Market
7.6.	Rest of The World Influenza diagnostics Market

Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	 3AM healthcare
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	   Alere
8.2.3.	Meridian bioscience Inc.
8.2.4.	Quidel corporation
8.2.5.	Roche diagnostics corporation
8.2.6.	SA Scientific
8.2.7.	Thermo fisher scientific Inc.
8.2.8.	 Abbott
8.2.9.	Becton, Dickinson and Company
8.2.10.	F. Hoffmann-La Roche Ltd
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Influenza diagnostics Market valued approximately USD 2.2 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2019-2026. Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus. The seasonal influenza virus has three types, namely influenza B, influenza A, and influenza C that are differentiated on the basis of two major surface proteins namely, hemagglutinin (HA) and neuraminidase (NA). Various serotypes are seen based on differences in these surface proteins that determine the antibody response to the viruses. Increasing prevalence of influenza coupled with increasing research funding for the influenza diagnostics are key driving forces of the market. Furthermore, growing demand for faster diagnostics and control of influenza is expected to create significant growth opportunity in the market over the forecast period. However, complex regulatory guidelines for the approval of new diagnostic test is expected to hamper the market growth over the forecast period.
The regional analysis of global Influenza Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the growing prevalence of influenza. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing healthcare expenditure, government initiatives coupled with demand for advanced diagnostic technologies would create lucrative growth prospects for the Influenza Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
3AM healthcare
Alere
Meridian bioscience Inc.
Quidel corporation
Roche diagnostics corporation
SA Scientific
Thermo fisher scientific Inc.
Abbott
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test type:

RIDT
RT-PCR
Cell culture

By End Use:

Hospitals
Laboratories
POCT

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Influenza diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…